{"id":839794,"date":"2025-04-22T07:03:03","date_gmt":"2025-04-22T11:03:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/"},"modified":"2025-04-22T07:03:03","modified_gmt":"2025-04-22T11:03:03","slug":"autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/","title":{"rendered":"Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">LONDON, April  22, 2025  (GLOBE NEWSWIRE) &#8212; Autolus Therapeutics plc\u00a0(Nasdaq: AUTL), an early commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announces that it will release its first quarter 2025 financial results and operational highlights before open of US markets on Thursday, May 8, 2025.<\/p>\n<p align=\"justify\">Management will host a conference call and webcast at\u00a08:30 am EDT\/13:30 pm BST to discuss the company\u2019s financial results and provide a general business update. Conference call participants should pre-register using this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kMuOIK9wqqTJzmhtj78HD1t1Qj1onRlTJI1FbFhHZ_85E638Hx9KpthV8v2iXG8otG2qMBJ7kbpVSRqYEJEMLKYRxAk_wP-IzoV-MYUV5hq_vABjV3yD-O3De3Ltbu6OwgCUCvXMVQgS7aLi6OqiX0oCb7Bpwp69bMsDxlCNGZ0lSS6p7dh_Rb6hjPcSS53lnQ2OvI8koKMJr-ApIkSNnzaHq5fXnlqU4rTzqJJJp4RYinqoNcG592gGyLlNYb6-LvibnJeTS74dKKsnBk9lT167PPrCMTo2L-vBeHrnYYZcak-hpZmAfFoVesfj2PgtVCCP-aruybklHxpc9A1XTwGOeJJI9ncwQb1OakQHIhb-ZQ2gQpLYMNtVf24W36fV6Gew_abHuSXSMoTEU6uDqGm9XN0TYW0l3CUlgPSIWyZGjeigyjQ5btdjj05-vPrTGqULgmdviEl_S-z2XWuJ1cemukQaDnUiBDlKoPaw08BfBXQnsMtx5N78FG3HYKfVf5ZG2UzfrJ5aSBDjHVZ9B2kt22HaUf2Z5CHLwiR8z_xcGCc5oOC92qeykoLT2cD5g8cFmuhjLTgpTwF50SuuevDlMZwnNR9mnp8_6DGx2L0klfWW3ZKZ6ziHEQF84UZI\" rel=\"nofollow\" target=\"_blank\">link<\/a> to receive the dial-in numbers and a personal PIN, which are required to access the conference call.<\/p>\n<p align=\"justify\">A simultaneous audio webcast and replay will be accessible on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K00FdMmspKHsZGDcPfKs5OobtnF6YkN6HbZqowXujCHvhge9jvzlf033ATE1v65JVpd5366mY5iKia3GOmQPq_VUh2YUqmlQhXfnp1fu10Xkdv1OsrihXQtuICxzYhQIY096vf-7UbL1RSTod30WHw==\" rel=\"nofollow\" target=\"_blank\">events section<\/a> of Autolus\u2019 website.<\/p>\n<p align=\"justify\">\n        <strong>About Autolus Therapeutics plc<\/strong><br \/>\n        <br \/>Autolus Therapeutics plc\u00a0(Nasdaq: AUTL) is an early commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation T cell therapies for the treatment of cancer and autoimmune disease. Using a broad suite of proprietary and modular T cell programming technologies, Autolus is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize target cells, break down their defense mechanisms and eliminate these cells. Autolus has an FDA approved product, AUCATZYL, and a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=txkuobpw2l5FaUGWSUNHyJcU5abvjTmGQT-3E2riFRs0DeafwqOksZBHT2rcotcvB1hKS5cyuh_rt0vEPBNRiA==\" rel=\"nofollow\" target=\"_blank\">www.autolus.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Contact:\u00a0<\/strong>\u00a0<\/p>\n<p align=\"justify\">Amanda Cray\u00a0<br \/>+1 617-967-0207\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Xlh0tOKmNb8-WZKt9QX65xP5ZN99rqAfPTXDrO7rqQDUCYCKlPBdN5GVmtXYcmMONTN62G3GPiVXzWfa6oc9eFfnC381wsIC1bs7ixEgk5E=\" rel=\"nofollow\" target=\"_blank\">a.cray@autolus.com<\/a>\u00a0<\/p>\n<p align=\"justify\">Olivia Manser\u00a0<br \/>+44 7780 471 568\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A7SL9oDNf7CZtbq_OurFOJ15YzV5Im2-BiF0VRkLTe-VeBDP63OWTEmeqVyx4uIvsjW0_QlBqyiNcWAw9DSA7uURXLxsleNBw-dVzEt-o9o=\" rel=\"nofollow\" target=\"_blank\">o.manser@autolus.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTcyNyM2ODk2MDk5IzIwOTk2MzA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YmJkNTllM2YtYjdkMi00NGNmLTgwMjMtZTY1MWIwYjYwMWYzLTExMTEyMDEtMjAyNS0wNC0yMi1lbg==\/tiny\/Autolus-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LONDON, April 22, 2025 (GLOBE NEWSWIRE) &#8212; Autolus Therapeutics plc\u00a0(Nasdaq: AUTL), an early commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announces that it will release its first quarter 2025 financial results and operational highlights before open of US markets on Thursday, May 8, 2025. Management will host a conference call and webcast at\u00a08:30 am EDT\/13:30 pm BST to discuss the company\u2019s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call. A simultaneous audio webcast and replay will be accessible on the events section of Autolus\u2019 website. About Autolus Therapeutics &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-839794","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LONDON, April 22, 2025 (GLOBE NEWSWIRE) &#8212; Autolus Therapeutics plc\u00a0(Nasdaq: AUTL), an early commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announces that it will release its first quarter 2025 financial results and operational highlights before open of US markets on Thursday, May 8, 2025. Management will host a conference call and webcast at\u00a08:30 am EDT\/13:30 pm BST to discuss the company\u2019s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call. A simultaneous audio webcast and replay will be accessible on the events section of Autolus\u2019 website. About Autolus Therapeutics &hellip; Continue reading &quot;Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-22T11:03:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTcyNyM2ODk2MDk5IzIwOTk2MzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025\",\"datePublished\":\"2025-04-22T11:03:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\\\/\"},\"wordCount\":250,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNTcyNyM2ODk2MDk5IzIwOTk2MzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\\\/\",\"name\":\"Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNTcyNyM2ODk2MDk5IzIwOTk2MzA=\",\"datePublished\":\"2025-04-22T11:03:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNTcyNyM2ODk2MDk5IzIwOTk2MzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNTcyNyM2ODk2MDk5IzIwOTk2MzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/","og_locale":"en_US","og_type":"article","og_title":"Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - Market Newsdesk","og_description":"LONDON, April 22, 2025 (GLOBE NEWSWIRE) &#8212; Autolus Therapeutics plc\u00a0(Nasdaq: AUTL), an early commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announces that it will release its first quarter 2025 financial results and operational highlights before open of US markets on Thursday, May 8, 2025. Management will host a conference call and webcast at\u00a08:30 am EDT\/13:30 pm BST to discuss the company\u2019s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call. A simultaneous audio webcast and replay will be accessible on the events section of Autolus\u2019 website. About Autolus Therapeutics &hellip; Continue reading \"Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-22T11:03:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTcyNyM2ODk2MDk5IzIwOTk2MzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025","datePublished":"2025-04-22T11:03:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/"},"wordCount":250,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTcyNyM2ODk2MDk5IzIwOTk2MzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/","name":"Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTcyNyM2ODk2MDk5IzIwOTk2MzA=","datePublished":"2025-04-22T11:03:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTcyNyM2ODk2MDk5IzIwOTk2MzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNTcyNyM2ODk2MDk5IzIwOTk2MzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-report-first-quarter-2025-financial-results-and-host-conference-call-on-may-8-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/839794","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=839794"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/839794\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=839794"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=839794"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=839794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}